Research use only.  Educational reference. Not medical advice. Not for human consumption.
⚡ Cellular Metabolism Cofactor

NAD+ (1000 mg Vial) Dosage Protocol

NAD+ is a critical coenzyme involved in mitochondrial energy production, sirtuin activation, and DNA repair. Cellular NAD+ levels decline with age — restoring them is an active longevity-research area. This page covers the 1000 mg vial.

⚡ Quickstart Highlights

Vial size
1000 mg
Reconstitution
3 mL BAC water → 333.33 mg/mL
1 U-100 unit =
3333.3 mcg
Frequency
Daily during cycle

Dosing & Reconstitution Guide

Route: Subcutaneous (slow infusion sometimes)  |  Frequency: Daily during cycle  |  Half-life: Tissue NAD+ ~hours

Standard Approach (3 mL = 333.33 mg/mL)

Reconstituting with 3 mL bacteriostatic water produces a concentration of 333.33 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.

Phase / ProtocolDoseU-100 UnitsVolumeDoses per vial
Week 1 (titration)50 mg15.0 units0.15 mL20 doses
Week 275 mg22.5 units0.23 mL13 doses
Weeks 3–16 (maintenance)100 mg30.0 units0.30 mL10 doses

Reconstitution Steps

  1. Wipe the vial stopper and BAC water vial with alcohol; let dry.
  2. Draw 3 mL of bacteriostatic water into a sterile syringe.
  3. Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
  4. Gently swirl until fully dissolved. Do not shake.
  5. Label with reconstitution date. Refrigerate at 2–8°C; use within 14 days.

Supplies Needed

Estimates for an 8-week and 12-week cycle at 100 mg per dose, daily during cycle (7 doses/week).

Item8-Week Cycle12-Week Cycle
NAD+ (1000 mg) vials6 vials9 vials
Insulin syringes (U-100)5684
Bacteriostatic water (10 mL)2 × 10 mL3 × 10 mL
Alcohol swabs1 × 100-pack2 × 100-pack

Protocol Overview

NAD+ injection protocols vary widely. The most-cited research approaches are slow daily subcutaneous (8–14 days), or weekly IV infusions (45–60 min slow drip). Both raise tissue NAD+ levels rapidly compared to oral precursors (NMN, NR).

The injection-site burning sensation is the primary tolerability constraint — slow injection mitigates significantly.

Dosing Protocol

Daily titration (subcutaneous):

IV protocol: Some clinical protocols use 500–1000 mg slow IV (45–60 min), 1–2× weekly — clinical setting required. Do not attempt IV at home.

Cycle structure: 8–14 day intensive courses, then 2–4 week break. Some users run 5 days on / 2 days off continuously.

Burning sensation: Inject slowly (over 30+ seconds for sub-Q) to minimize. Splitting larger doses into two injections at different sites also helps.

Storage Instructions

StateTemperatureDuration
Lyophilized−20°C (−4°F)Up to 24 months, dry & dark
Reconstituted2–8°C (35–46°F)Up to 14 days, protect from light

Important Notes

⚠ Research Use Only: NAD+ for subcutaneous use is investigational.

How This Works

NAD+ (nicotinamide adenine dinucleotide) is a small-molecule coenzyme present in every living cell. It functions as the central electron carrier in cellular metabolism, alternating between oxidized (NAD+) and reduced (NADH) forms. Beyond its metabolic role, NAD+ is a substrate for sirtuins (longevity-related deacetylases) and PARPs (DNA-repair enzymes).

Cellular NAD+ levels decline ~50% between age 40 and 60, paralleling mitochondrial dysfunction and aging-related disease. Direct NAD+ administration bypasses synthesis pathways from precursors (NMN, NR) and rapidly raises tissue NAD+ levels.

Potential Benefits & Side Effects

Potential Benefits

Side Effect Profile

Lifestyle Factors

Injection Technique

References

1
Verdin E. 'NAD+ in aging, metabolism, and neurodegeneration' — Science, 2015 View source ↗
2
Rajman L et al. 'Therapeutic Potential of NAD-Boosting Molecules' — Cell Metab, 2018 View source ↗